Crossmark

Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma

Crossref DOI link: https://doi.org/10.1186/s13045-018-0612-6

Published Online: 2018-05-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Santo, Carmela

Cheng, Paul

Beggs, Andrew

Egan, Sharon

Bessudo, Alberto

Mussai, Francis https://orcid.org/0000-0003-3342-0047
Funding

Funding for this research was provided by:

Cancer Research UK
License Information

Text and Data Mining valid from 2018-05-18
More Information

Article History

Received: 14 March 2018

Accepted: 2 May 2018

First Online: 18 May 2018

Ethics approval and consent to participate

: In accordance with the Declaration of Helsinki, patient samples were obtained after written, informed consent. South Central-Hampshire Regional Ethics Committee (10/H0501/39) and local hospital trust research approval for the study was granted.

: The patient and study members have provided consent for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.